Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Metadata
Title
Recommendations for treatment with IMRT for prostate and head-neck cancer
Authors
Carmen Maceira Ma. del Rozas
Teresa Rey Liste
Ángela L. García Caeiro
Julio García Comesaña
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 4/2006
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02664936

Other articles of this Issue 4/2006

Clinical and Translational Oncology 4/2006 Go to the issue

Educational Series

Proteomic analysis in cancer research: potential application in clinical use

Brief Research Article

Mammary hamartoma

Research Articles

Voice quality assessment after laryngeal cancer radiotherapeutic treatment at initial stages

Research Articles

Damage assessment in gastric cancer treatment with adjuvant radiochemotherapy: calculation of the NTCP’s from the differential HDV of the organs at risk

News and Views

The long and tortuous way towards the remedy

Educational Series

Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits